GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

A booming gray market is turning kitchens into makeshift pharmacies as Americans chase cheaper alternatives to high-priced ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

People with lip filler should be extra careful when taking GLP-1 medication like Ozempic and Mounjaro, after one woman ...